<DOC>
	<DOCNO>NCT01174472</DOCNO>
	<brief_summary>The aim study compare feasibility effectiveness , mean immediate long-term result , drug elute balloon ( DEB ) versus conventional balloon angioplasty treatment fail dialysis access .</brief_summary>
	<brief_title>Drug Eluting Balloon Angioplasty Dialysis Access Treatment</brief_title>
	<detailed_description>In total 40 patient already diagnose hemodynamically significant stenosis dialysis AVF AVG ( include venous outflow lesion ) , program undergo percutaneous transluminal angioplasty department , sign inform consent randomize either receive DEB ( Paclitaxel elute balloon ) , conventional balloon therapy . The protocol include description patient 's demographic ( age , gender , dialysis access detail , risk factor ) procedural detail , well immediate result long-term follow .</detailed_description>
	<mesh_term>Paclitaxel</mesh_term>
	<criteria>Angiographic clinical diagnosis dysfunctional dialysis access due one stenotic lesion . Patients AVF AVG Fistula graft vessel diameter range 3 mm 12 mm Fistula graft vessel diameter &lt; 3 mm &gt; 12 mm History severe allergic reaction contrast medium Intolerance aspirin and/or clopidogrel Systemic coagulopathy hypercoagulation disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Dialysis access</keyword>
	<keyword>angioplasty</keyword>
	<keyword>drug elute balloon</keyword>
</DOC>